258 related articles for article (PubMed ID: 30895525)
1. Biologic Therapy in the Treatment of Cutaneous Sarcoidosis: A Literature Review.
Dai C; Shih S; Ansari A; Kwak Y; Sami N
Am J Clin Dermatol; 2019 Jun; 20(3):409-422. PubMed ID: 30895525
[TBL] [Abstract][Full Text] [Related]
2. TNF-α: a treatment target or cause of sarcoidosis?
Amber KT; Bloom R; Mrowietz U; Hertl M
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2104-11. PubMed ID: 26419478
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
Silvagni E; Bortoluzzi A; Carrara G; Zanetti A; Govoni M; Scirè CA
BMJ Open; 2018 Sep; 8(9):e021447. PubMed ID: 30206082
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous sarcoidosis therapy updated.
Badgwell C; Rosen T
J Am Acad Dermatol; 2007 Jan; 56(1):69-83. PubMed ID: 17190623
[TBL] [Abstract][Full Text] [Related]
5. Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study.
Wu N; Lee YC; Shah N; Harrison DJ
Clin Ther; 2014 Aug; 36(8):1231-41, 1241.e1-3. PubMed ID: 25062652
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous sarcoidosis masquerading as psoriatic plaques.
Argraves M; Sloan SB; Dadras SS
Dermatol Online J; 2015 Apr; 21(4):. PubMed ID: 25933072
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based therapy for cutaneous sarcoidosis.
Doherty CB; Rosen T
Drugs; 2008; 68(10):1361-83. PubMed ID: 18578557
[TBL] [Abstract][Full Text] [Related]
8. The Role of Biologic Therapies in Dermatology.
Fathi R; Armstrong AW
Med Clin North Am; 2015 Nov; 99(6):1183-94. PubMed ID: 26476247
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab for treatment of cutaneous sarcoidosis.
Heffernan MP; Smith DI
Arch Dermatol; 2006 Jan; 142(1):17-9. PubMed ID: 16415380
[No Abstract] [Full Text] [Related]
10. Anti-TNF therapeutics for the treatment of sarcoidosis.
Crommelin HA; Vorselaars AD; van Moorsel CH; Korenromp IH; Deneer VH; Grutters JC
Immunotherapy; 2014; 6(10):1127-43. PubMed ID: 25428650
[TBL] [Abstract][Full Text] [Related]
11. Sarcoidosis: an update on current pharmacotherapy options and future directions.
Brito-Zerón P; Pérez-Alvarez R; Pallarés L; Retamozo S; Baughman RP; Ramos-Casals M;
Expert Opin Pharmacother; 2016 Dec; 17(18):2431-2448. PubMed ID: 27817209
[TBL] [Abstract][Full Text] [Related]
12. Intralesional biologics for inflammatory dermatoses: A systematic review.
Seivright JR; Villa NM; De DR; Hsiao JL; Shi VY
Dermatol Ther; 2022 Feb; 35(2):e15234. PubMed ID: 34825744
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous sarcoidosis: an intriguing model of immune dysregulation.
Ruocco E; Gambardella A; Langella GG; Lo Schiavo A; Ruocco V
Int J Dermatol; 2015 Jan; 54(1):1-12. PubMed ID: 25312788
[TBL] [Abstract][Full Text] [Related]
14. Medical therapy of sarcoidosis.
Baughman RP; Lower EE
Semin Respir Crit Care Med; 2014 Jun; 35(3):391-406. PubMed ID: 25007090
[TBL] [Abstract][Full Text] [Related]
15. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists.
Thielen AM; Barde C; Saurat JH; Laffitte E
Dermatology; 2009; 219(1):59-62. PubMed ID: 19468200
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them.
Baughman RP; Lower EE; Drent M
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec; 25(2):76-89. PubMed ID: 19382527
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab--a paradoxical effect? A case report.
Santos G; Sousa LE; João AM
An Bras Dermatol; 2013; 88(6 Suppl 1):26-8. PubMed ID: 24346872
[TBL] [Abstract][Full Text] [Related]
18. Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial.
Baughman RP; Judson MA; Lower EE; Drent M; Costabel U; Flavin S; Lo KH; Barnathan ES;
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):289-95. PubMed ID: 26847095
[TBL] [Abstract][Full Text] [Related]
19. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
Ross C; Marshman G; Grillo M; Stanford T
Australas J Dermatol; 2016 May; 57(2):137-40. PubMed ID: 25754697
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis.
Pariser RJ; Paul J; Hirano S; Torosky C; Smith M
J Am Acad Dermatol; 2013 May; 68(5):765-73. PubMed ID: 23276549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
